Harrow (HROW) Total Liabilities (2010 - 2026)
Harrow (HROW) posted quarterly Total Liabilities of $391.2 million for Q1 2026, up 26.98% year-over-year from $308.1 million in Q1 2025, and up 12.61% quarter-over-quarter from $347.4 million in Q4 2025.
Harrow (HROW) Total Liabilities (2010 - 2026) Analysis & Trends
Harrow's Total Liabilities history runs 17 years deep, the most recent figure standing at $391.2 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 26.98% year-over-year to $391.2 million; the TTM figure through Mar 2026 stood at $391.2 million (up 26.98% YoY), while the FY2025 annual figure was $347.4 million, up 8.67% from the prior year.
- Total Liabilities for Q1 2026 stood at $391.2 million, up from $347.4 million in the prior quarter.
- The five-year high for Total Liabilities was $391.2 million in Q1 2026, with the low at $87.9 million in Q1 2022.
- The 5-year median for Total Liabilities is $241.8 million (2023), against an average of $236.2 million.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities jumped 209.56% in 2022, then advanced 7.65% in 2025.
- Harrow's Total Liabilities stood at $130.1 million in 2022, then surged by 85.77% to $241.8 million in 2023, then surged by 32.23% to $319.7 million in 2024, then advanced by 8.67% to $347.4 million in 2025, then grew by 12.61% to $391.2 million in 2026.
- Business Quant data shows HROW's Total Liabilities at $391.2 million in Q1 2026, $347.4 million in Q4 2025, and $316.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -21.66 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 32.10 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 11.93 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 50.85 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 819.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 20.78 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.67 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.97 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 2.12 Bn |
| 10 | Harrow | 1.55 Bn | 1.46 Bn | 50.36 Mn | 401.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 401.97 Mn |
| Mar 31, 2026 | 391.19 Mn |
| Dec 31, 2025 | 347.39 Mn |
| Sep 30, 2025 | 316.41 Mn |
| Jun 30, 2025 | 295.73 Mn |
| Mar 31, 2025 | 308.07 Mn |
| Dec 31, 2024 | 319.67 Mn |
| Sep 30, 2024 | 293.92 Mn |
| Jun 30, 2024 | 248.45 Mn |
| Mar 31, 2024 | 235.33 Mn |
| Dec 31, 2023 | 241.75 Mn |
| Sep 30, 2023 | 210.66 Mn |
| Jun 30, 2023 | 201.94 Mn |
| Mar 31, 2023 | 195.97 Mn |
| Dec 31, 2022 | 130.14 Mn |
| Sep 30, 2022 | 98.13 Mn |
| Jun 30, 2022 | 92.67 Mn |
| Mar 31, 2022 | 87.86 Mn |
| Dec 31, 2021 | 87.40 Mn |
| Sep 30, 2021 | 86.57 Mn |